Stock Events

Stock Events

Olema Pharmaceuticals 

$10.75
43
+$0.02+0.19% Friday 20:00
+$0.11+1.02%Friday 23:30After hours

Statistics

Day High
10.76
Day Low
10.74
52W High
36.26
52W Low
6.35
Volume
13,041
Avg. Volume
-
Mkt Cap
940.6M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.64
-0.54
-0.45
-0.36
Expected EPS
-0.636781
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-162.45MNet Income

Analyst Ratings

40.50Average Price Target
The highest estimate is 59.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
86%
Hold
14%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OLMA. It's not an investment recommendation.
NVIDIA
12
NVDA
Alphabet
11
GOOGL
Microsoft
10
MSFT
Broadcom
9
AVGO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Puma Biotechnology
PBYI
Mkt Cap467.68M
Puma Biotechnology focuses on the development and commercialization of drugs for the treatment of various forms of cancer, directly competing with Olema's cancer-focused therapies.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies for infectious diseases, cancer, and inflammatory diseases, overlapping with Olema's research in cancer treatments.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that offers a wide range of healthcare products, including innovative medicines in oncology, directly competing with Olema Pharmaceuticals in the cancer treatment market.
Merck
MRK
Mkt Cap366B
Merck is known for its high-quality cancer drugs and vaccines, making it a direct competitor to Olema Pharmaceuticals in the oncology sector.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses worldwide, with a strong focus on oncology, competing with Olema's cancer therapies.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca operates in various therapeutic areas, including oncology, making it a competitor to Olema Pharmaceuticals in the development of cancer treatments.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company whose focus on cancer drugs and innovative therapies places it in direct competition with Olema Pharmaceuticals.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including oncology/hematology, which competes with Olema Pharmaceuticals' focus on cancer treatment.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines for oncology, competing with Olema Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment, develops and markets treatments for various diseases, including cancer, making it a competitor to Olema Pharmaceuticals in the oncology space.

About

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Show more...
CEO
Sean Bohen
Employees
150
Country
United States
ISIN
US68062P1066

Listings

XNAS
US
OLMA
BOATS
BOATS
OLMA.BOATS

0 Comments

Share your thoughts

FAQ

What is Olema Pharmaceuticals stock price today?▼
The current price of OLMA is $10.75 USD — it has increased by +0.19% in the past 24 hours. Watch Olema Pharmaceuticals stock price performance more closely on the chart.
What is Olema Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Olema Pharmaceuticals stocks are traded under the ticker OLMA.
Is Olema Pharmaceuticals stock price growing?▼
OLMA stock has risen by +4.67% compared to the previous week, the month change is a -7.17% fall, over the last year Olema Pharmaceuticals has showed a +29.36% increase.
What is Olema Pharmaceuticals market cap?▼
Today Olema Pharmaceuticals has the market capitalization of 940.6M
When is the next Olema Pharmaceuticals earnings date?▼
Olema Pharmaceuticals is going to release the next earnings report on November 10, 2026.
What were Olema Pharmaceuticals earnings last quarter?▼
OLMA earnings for the last quarter are -0.61 USD per share, whereas the estimation was -0.55 USD resulting in a -10.62% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Olema Pharmaceuticals revenue for the last year?▼
Olema Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Olema Pharmaceuticals net income for the last year?▼
OLMA net income for the last year is -162.45M USD.
How many employees does Olema Pharmaceuticals have?▼
As of September 05, 2026, the company has 150 employees.
In which sector is Olema Pharmaceuticals located?▼
Olema Pharmaceuticals operates in the Health & Wellness sector.
When did Olema Pharmaceuticals complete a stock split?▼
Olema Pharmaceuticals has not had any recent stock splits.
Where is Olema Pharmaceuticals headquartered?▼
Olema Pharmaceuticals is headquartered in SAN FRANCISCO, United States.